This site is intended for health professionals only

Home / News / Serious shortage protocols issued for Fluoxetine and Salazopyrin

Serious shortage protocols issued for Fluoxetine and Salazopyrin

By Isabel Shaw

22 Oct 2020

Two new serious shortage protocols (SSPs) for Fluoxetine 30mg capsules and Salazopyrin EN-Tabs 500mg have been issued by the Department of Health and Social Care (DHSC) to combat shortages.

The SSPs, which apply to all pharmacies in England, Wales and Northern Ireland, were introduced with immediate effect on Tuesday (20 October) and are due to expire on 4 December (Salazopyrin) and 22 December (Fluoxetine).

The protocols were put in place in response to ‘significant ongoing disruption’ to the supply of both drugs, PSNC said.

Both SSPs provide pharmacists with procedures to follow for supplying a suitable alternative product to patients.

Fluoxetine 30mg capsules were subject to a SSP in October last year, along with two other strengths of the antidepressant.

Earlier this month (5 October), the SSP for Fluoxetine 40mg capsules was withdrawn after ‘sufficient stock’ of the drug had been made available to meet ‘normal demand’.

A full list of active SSPs have been published on the NHS Business Services Authority’s website.

Want news like this straight to your inbox?

Latest News

Former nurse Maria Caulfield appointed pharmacy minister
Maria Caulfield MP has been appointed as a health minister, with responsibilities including pharmacy, following...
Ministers plan to ‘take action’ on overprescribing
Ministers have pledged to ‘take action’ on overprescribing after an official review concluded that 10%...
electronic prescribing
Electronic prescribing to be rolled out in Wales within five years
Electronic prescribing will be implemented across Wales within the next three to five years, the...